Free Trial
OTCMKTS:CRLBF

Cresco Labs 3/5/2026 Earnings Report

Cresco Labs logo
$1.03 -0.07 (-6.36%)
As of 05/8/2026 03:59 PM Eastern

Cresco Labs EPS Results

Actual EPS
-$0.02
Consensus EPS
-$0.02
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Cresco Labs Revenue Results

Actual Revenue
$164.04 million
Expected Revenue
$160.87 million
Beat/Miss
Beat by +$3.16 million
YoY Revenue Growth
N/A

Cresco Labs Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cresco Labs Earnings Headlines

Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Cresco Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email.

About Cresco Labs

Cresco Labs (OTCMKTS:CRLBF) is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs’ operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.

The company’s product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets. Cresco Labs also operates retail dispensaries under the Sunnyside banner, providing consumers with standardized dispensary experiences and educational resources aimed at promoting responsible consumption. In addition to branded consumer products, the company offers white-label manufacturing and distribution services to third-party cannabis operators seeking scalable production solutions.

Founded by industry veterans Charlie Bachtell and Joe Caltabiano, Cresco Labs traces its origins to a 2013 cultivation and processing venture in Illinois. Since rebranding as Cresco Labs, the company has pursued a growth-through-acquisition strategy, adding licensed operations in states such as Florida, Pennsylvania, Massachusetts, Michigan, California, Colorado, Ohio, Nevada and Arizona. Key acquisitions have included regional producers and dispensary chains, enabling Cresco Labs to establish a diversified footprint and centralized supply chain infrastructure.

Under its leadership team, Cresco Labs emphasizes rigorous quality control, regulatory compliance and operational efficiency. The company maintains in-house scientific teams to oversee product development and analytical testing, ensuring consistency across its market portfolio. With expanding retail and wholesale channels, Cresco Labs aims to support long-term market growth by balancing consumer-driven innovation with adherence to evolving state regulations.

View Cresco Labs Profile